Physicians at medical practices affiliated with Solaris Health, the nation’s leading healthcare management company in the urological field, are the first throughout the country to provide a new ...
BioProtect, a company providing biodegradable spacing solutions, recently announced it closed its most recent funding round with $28 million from investors. The round was led by MVM Partners, with ...
BETHLEHEM, Pa., Nov. 7, 2025 /PRNewswire/ -- Following publication of BioProtect's pivotal randomized trial in the International Journal of Radiation Oncology, Biology, Physics (Red Journal) and ...
TOKYO, May 26, 2026 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to ...
Olympus has agreed to acquire BioProtect in a $270m deal, giving the company a commercial device that will help expand its prostate cancer care provision. Israel-based BioProtect's lead product is ...
TZUR YIGAL, Israel, Aug. 28, 2023 /PRNewswire/ -- Israeli medical devices manufacturer BioProtect Ltd. announced today that their BioProtect Balloon Implant ™ System has been cleared by the FDA. The ...
BioProtect’s biodegradable balloon spacer is designed to protect healthy tissue during prostate cancer radiation therapy. (photoman/iStock/Getty Images Plus) Olympus has signed a definitive agreement ...
BioProtect develops implant technologies that contribute to improving prostate cancer care and enhancing patients' quality of life. Its flagship Balloon Spacer system is designed to provide consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results